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Summary: A procedure based on affinity chromatography for the extraction of ocytocin is described. Ocytocin
antibody, covalently attached to a magnetizable iron Suspension, retains its ability to bind ocytocin from blood
plasma. The conjugate can be reused several times. RecoVery of ocytocin was 60-70%, and the detection limit for
the extraction assay was about l pg per tube. The specificity of the extraction method was characterized by HPLC/
RIA on specimens extracted from blood plasma. The extracted material was found to be chomatographically ident-
ical with the reference ocytocin preparation. Comparison of RIA data for the same samples extracted by immunoex-
traction (y) and adsorption (x) showed a linear regression of y = 0.83 + 2.12, r = 0.81, n = 17.
Introduction
The neurohypophysial hormone, ocytocin, has various
functions. It acts äs a peripheral hormone, äs a neuro-
peptide in the brain, and äs a paräcrine substance in sev-
eral tissues. As a hormone, it regulates parturition and
lactation; äs a neuropeptide, it participates in memory
processes, maternal and sexual behaviour, arid the devel·
opment of tolerance and addiction to narcptic drugs; äs
a paracrine factor, it plays a role in various peripheral
prgans (e. g. the ovary). Its biological importänce stimvu
lated various groups to develop methods for measure-
ment of the hormone. Its basal circülating levels in the
blood are low. Most of the RIA determinatiöns involve
extraction techniques, prior to the assay of ocytocin in
the plasma (1-^5). Extraction is necessary to eliminate
non-specific interfering substances in the plasma, but the
procedures are time^consuming and may involve signifi-
cant and variable losses of ocytocin.
Our ahn was to study the ocytocin extraction based ön
affinity chromatography with magnetizable iron par-
ticles. For this purpose, the ocytocin antibody was coval-
ently attached to the surface of aii iron Suspension, and
its ability to bind and extract ocytocin from human and
rat plasma was examined. Additionally, the reusability
of the iron-antibody conjugate was investigated.
Materials and Methods
Human blood was collected in EDTA-containing tubes at 8-9 a. m.
from the antecubital vein of healthy subjects in the supine position.
After centrifugation for 10 min at 1500 g and 4 °C, the plasma was
collected in polystyrene tubes and stored at —70 °C until extrac-
tion.
Adult male Wistar rats weighing 180—230 g were used. Blood
samples were obtained from the trunks of decapitated rats between
8 and 10 a. m., collected in polystyrene tubes containing EDTA in
isotönic saline, maintained on an ice-bath, subsequently centri-
fuged at 2000 g for 10 min at 4 °C and stored at -70 °C until ex-
traction.
Materials
The sources of materials were äs follows: synthetic ocytocin (Ba-
chern, Bubendorf, Switzerländ), N^terminal Biomag magnetic par-
tieles (Advanced Magnetics, Inc., Cambridge, MA), bis-succinim-
idyl suberate (Serva, Heidelberg, Germany), trifluoroacetic acid
(Fluka, Germany), methanol (HPLC grade), Veronal-Na (Merck,
Germany), bovine serum albumin, L-cystine (Sigma, St. Louis,
USA). All other chemicals were of analytical grade.
The RIA buffer cpnsisted of 20 mmol of Veronal-Na, 10 mmol of
EDTA-Na2, 0.14 mol of NaCl, 5 g of bovine serum albumin and
0.01 g of L-cystine per litre, pH = 8.
Antibody preparation and purißcation
The ocytocin antiserum against ocytooin-e-aminocaprilyl bovine
thyroglobulin was produced in rabbit (6).
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The oeytocin antibody was purified bcfore use in the coupling pro-
cedure. Tlie IgG fraction of the native antiserum was precipitated
by dropwise addition of an equal volume of 360 g/l sodium sul-
phate. After centrifugation, the precipitate was washed with 18 g/l
sodium sulphate. The pellet was dissolved in 0.03 mol/1 HC1, and
0.03 mol/1 NaOH was added dropwise until opalescence and pre-
cipitation occurred. The mixture was centrifuged at 2000g for 15
min at 4 °C, and the resulting pellet was dissolved in isotonic saline
and dialysed against distilled water for 2 days at 4 °C. The dialysed
fraction was lyophilized.
For the RIA, 50 μΐ of oeytocin antibody (at a final dilution of
l : 70000) were added to 100 μΐ of sample or Standard, then incu-
bated for 24 h at 4 °C, followed by addition of iodine-labelled oey-
tocin (10000 counts/min in 50 μΐ). After incubation for a further
24 h, the bound and free conjugates were separated by adding 50 μΐ
of horse serum and 500 μΐ of polyethyleneglyeol in water, 300 g/l.
After centrifugation at 1500g for 15 minutes, the radioactivity of
the pellet was measured on a Wizard automatic gamma counter
(Wallac Oy, Finland), with subsequent calculation via the Multicalc
program (Wallac Oy, Finland).
Methods
Aniibody coupling to magnefic particles
The coupling procedure was performed according to the bis-suc-
cinimidyl suberate active ester method (7). Lyophilized (10-20
mg) oeytocin antibody was coupled to l ml of magnetic suspen-
sion. The resulting antibody-coated particles were washed three to
four times with 0.03 mol/1 HC1, followed by 0.03 mol/1 NaOH,
then stored in assay buffer containing 0.2 g/l NaN3 (sodium azide)
s preservative. After immunoextraction, the sedimented magnetic
iron conjugate was washed twice with 500 μΐ of RIA buffer, made
up with assay buffer (containing 0.2 g/l sodium azide) to the final
volume (representing a two or fourfold dilution of the conjugate),
then stored at 4 °C.
Procedures
1mm unoextraction
One ml of human plasma was mixed with 200 μΐ of magnetic
Suspension diluted with assay buffer, and rotated end-over-end for
3 hours at 4 °C. To separate the particle-bound fraction, the tubes
were placed on a magnetic rack, the particles were sedimented
and the supernatant was discarded. The magnetic Suspension was
washed twice with 500 μΐ of assay buffer. The oeytocin was then
eluted from the magnetic iron conjugate with 400 μΐ of methanol/
water (80 + 20, by vol.) containing l ml/l trifluoroacetic acid. An
aliquot (300 μΐ) of the supernatant was dried under a nitrogen
stream. The residue was dissolved in 225 μΐ of RIA buffer and
analysed in duplicate (6).
Standard concentrations of oeytocin (0.8—100 pg per tube) were
prepared in assay buffer, or in "ocytocin-free plasma" and immuno-
extracted. Peptide-free plasma was made from pooled plasma
samples, pretreated with activated charcoal, centrifuged, and puri-
fied on Sep-Pak cartridge.
Adsorption method
The method was based on that described earlier (8). Lichroprep
Si60 (20 mg), distilled water (100 μΐ) and l mol/1 HC1 (400 μΐ)
were added to 2 ml of blood plasma in polypropylene tubes. The
mixture was agitated for 30 min then centrifuged. The supernatant
was discarded, the pellet washed twice with distilled water, and the
immunoreactive material eluted with acetone/water (60 + 40, by
vol.), evaporated and assayed.
Radioimmunoassay
A relatively sensitive in-house RIA was set up (6).
The oeytocin antibody affmity constant was 3.7 X l O9 mol/1. Cross
reaction with related peptides: oeytocin 100, vasotocin 0.11, ocy-
pressin 92.7, ocytocin^g 3.26, arginine-vasopressin 0.11%,
pressionic acid, melanostatin and ocytociii4_8 less than 0.05%.
[125I]Ocytocin was prepared by the method of Hunter & Green-
wood (9) and purified by two-step reverse-phase chromatography
(10). The specific radioactivity was about 70.3 TBq/mmol.
High performance liquid chromatography
The procedure was performed s described earlier (11). Eltiates of
39-39 immunoextracted human or rat plasma samples were pooled
and evaporated. The residues were dissolved in methanol/water
(30 + 70, by vol.) containing l ml/l trifluoroacetic acid. A Knaiier
HPLC System with gradient elution was used t chafacterize the
ocytocin-like immunoreacti vity. Aliquots of the dissolved samples
were loaded onto a Si-100-S RP-C18 column (5 μηι, 260 X 4.6
mm; BST, Budapest, Hungary) and eluted in a gradient System
of aqueous methanol, volume fractions 0.3-0.6 containing l ml/l
trifluoroacetic acid. To void contaminatiqn, specimens were run
in the sequence: blank, pooled human or rat samples, and finally
Standard oeytocin (0.5 ng) (12). The flow rate was 1.0 ml/min.
The eluted HPLC fractions were collected at l-min intervals for
up to 50 min and subjected to RIA (figs. la, b).
Res lts
The purified oeytocin antibody was coupled to N-tei>
minal magnetizable particles by the active ester method.
To exclude interference from endogenous oeytocin, the
conjugate was purified. Pretreatment of the antibody and
repeated washing of the iron-antibody conjugate led to
an increase in the binding and a reduction of the non-
specific binding to 3%.
The oeytocin binding capacity of the antibody-coupled
particles was determined by adding iodine-labelled oey-
tocin to serial dilutions of particle Suspension. The bind-
ing of the oeytocin tracer for the two- or fourfold diluted
Suspension was 85 and 78%, respectively. The Standard
curve was corrected for the ocytocin-free plasma, to
eliminate extraction losses and procedural errors.
The efficiency f the immunoextraction was determined
by adding different amounts of oeytocin to the rat
plasma pool. The f llowing recoveries wqre found·: 50
ng/1 61.7 ± 6.4%, 25 ng/1 71.2 ± 5.2% and 12.5 ng/1
74.2 ± 7.6%, respectively, (x ± SEM, n = 5).
Intra- and inter-assay coefficients of Variation deter-
mined on pooled rat plasma specimens at a concen-
tration of 12.1 ± 0.8 ng/1 were 7.9 and 13.9% (n = 6),
and at 46.7 ± 1.8 ng/1 5.3 and 10.1% (n = 6), respect-
ively. The detectiori limit of the assay after immunoex-
traction was l pg per tube.
The basal concentrati n in rat plasma was found to be
15.28 ng/1 ± 0,84 SEM, n =-6.
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The residual extracted Suspension was washed with RIA
buffer, made up to final volume and stored. Repeated
use of the conjugate was investigated. For three success-
ive immunoextractions of plasma the following ocytocin
values were obtained: 15.9 ± 4.0, 17.2 ± 3.4 and 14.6
± 3.0 ng/1, n = 6.
In HPLC, a major proportion of the ocytocin immuno-
reactivity in both the human and rat plasma samples mi-
grated together with the reference ocytocin preparation
(figs. l a, b).
To assess the accuracy of the immunoextraction, the re-
sults from immunoextracted human samples were com-
pared with those after adsorption extraction.
Regression of the results gave the equation y = 0.83
+ 2.12, r = 0.81, n = 17, SE slope 0.15, Yse 1.28.
females
males
females
males
After adsorption extraction
3.9 ± 0.6 SE, n. s., n = 11
4.1 ± 0.9 SE, n. s., n = 6
After immunoextraction
5.7 ± 0.6 SE, n. s., n = 11
5.2 ± 0.6 SE, n. s., n = 6
(two way Anova, followed by Scheffel rank test)
Discussion
A sensitive RIA is dependent on the production of a
highly specific and high-affinity antiserum with a radio-
labelled tracer of adequate specific activity. These
properties are necessary for direct measurement without
prior extraction (13, 14). Many techniques have been
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Fig. l a, b Elütion profile of immunoextracted human and rat
plasma samples. The elution was performed with a gradient System
of aqueous methanol -containing l ml/l trifluoroacetic acid!, and
fractions were radioimmunoassayed for ocytocin. The immuno-
reactive material was eluted at the same position äs the reference
ocytocin (—), in a) human (—) and b) rat (-—) plasma extracts.
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described for the extraction and concentration of ocyto-
cin from plasma. Most methods are based on simple
physicochemical techniques. An acid-ethanol mixture
has been used to precipitate proteins from blood samples
(15), while other, similar procedures involve the use of
acetone (16, 17). Another type of extraction procedure
involves the adsorption of ocytocin onto particülate
materials such äs Fuller's earth or glass beads (4, 18,
19). The main disadvantage of these methods is that the
procedures are non-specific, often work better from
acidified plasma and display mediocre recovery rates.
The Sep-Pak mini cartridge (20, 21), and an affinity ex-
traction method (22) give better results.
The HPLC results demonstrated that the immunoreac-
tive ocytocin is physicochemically identical to the corre^
sponding synthetic molecule. Slightly higher plasma
levels of ocytocin measured in the present study in com-
parison with the adsorption method or with other reports
could have been due to certain methodological vari-
ations.
Repeated use of the washed antibody-iron conjugate ap-
pears promising. It seems that the recovery äftef several
washing or elution Steps is reproducible. The weakly
bound peptides or proteins caü readily be removed.
In conclusion, we have set up a new and specific method
bäsed on affinity chromatography for the extraction of
ocytocin from blood plasma samples.
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